Eliot Finkel Investment Counsel, LLC Amgen Inc Transaction History

Eliot Finkel Investment Counsel, LLC

$157 Million
Q4 2024

A detailed history of Eliot Finkel Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Eliot Finkel Investment Counsel, LLC holds 25,827 shares of AMGN stock, worth $7.69 Million. This represents 4.29% of its overall portfolio holdings.

Number of Shares

25,827

Previous 25,877 0.19%

Holding current value

$7.69 Million

Previous $8.34 Million 19.26%

% of portfolio

4.29%

Previous 5.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$258.78 - $328.31 $12,938 - $16,415	-50 Reduced 0.19%	25,827 $6.73 Million
Q3 2024 Oct 17, 2024	SELL	$309.38 - $337.38 $88,173 - $96,153	-285 Reduced 1.09%	25,877 $8.34 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $15,765 - $19,158	-60 Reduced 0.23%	26,162 $8.17 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $120,991 - $146,052	-450 Reduced 1.69%	26,222 $7.46 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $136,799 - $154,326	-535 Reduced 1.97%	26,672 $7.68 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $160,707 - $199,523	-735 Reduced 2.63%	27,207 $7.31 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $7,499 - $8,867	35 Added 0.13%	27,942 $6.2 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $67,737 - $82,560	-300 Reduced 1.06%	27,907 $6.75 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $29,773 - $37,831	-130 Reduced 0.46%	28,207 $7.41 Million
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $17,956 - $20,252	-80 Reduced 0.28%	28,337 $6.39 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $23,071 - $25,674	-100 Reduced 0.35%	28,417 $6.91 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $74,551 - $82,473	-340 Reduced 1.18%	28,517 $6.9 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $161,092 - $184,356	-810 Reduced 2.73%	28,857 $6.49 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $4,245 - $4,974	-20 Reduced 0.07%	29,667 $6.31 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $65,402 - $72,559	280 Added 0.95%	29,687 $7.24 Million
Q1 2021 Aug 05, 2021	BUY	$221.91 - $258.6 $230,120 - $268,168	1,037 Added 3.66%	29,407 $7.32 Million
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $19,474 - $23,190	-90 Reduced 0.32%	28,370 $6.52 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $3,519 - $3,914	-15 Reduced 0.05%	28,460 $7.23 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $126,598 - $155,353	-640 Reduced 2.2%	28,475 $6.72 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $72,896 - $96,680	-400 Reduced 1.36%	29,115 $5.9 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $31,339 - $37,551	-180 Reduced 0.61%	29,515 $5.71 Million
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $31,672 - $37,127	-190 Reduced 0.64%	29,695 $5.47 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $36,174 - $40,776	-200 Reduced 0.66%	29,885 $5.68 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $8,920 - $10,412	-50 Reduced 0.17%	30,085 $5.86 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $216,789 - $244,401	-1,170 Reduced 3.74%	30,135 $6.25 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $4,981 - $5,595	-30 Reduced 0.1%	31,305 $5.78 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $121,989 - $142,560	-720 Reduced 2.25%	31,335 $5.34 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $21,942 - $24,516	-130 Reduced 0.4%	32,055 $5.57 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $5.38 Million - $6.15 Million	32,185	32,185 $6 Million

Others Institutions Holding AMGN

# of Institutions

3,161

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eliot Finkel Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eliot Finkel Investment Counsel, LLC with notifications on news.

Account

Eliot Finkel Investment Counsel, LLC Amgen Inc Transaction History